BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37862114)

  • 1. Comprehensive analysis of integrin αvβ3/α6β1 in prognosis and immune escape of prostate cancer.
    Liu Y; He JX; Ji B; Wang JF; Zhang L; Pang ZQ; Wang JS; Ding BC; Ren MH
    Aging (Albany NY); 2023 Oct; 15(20):11369-11388. PubMed ID: 37862114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictive value of pyroptosis for the prognosis and immune escape of bladder cancer.
    Liu Y; Pang ZQ; Han YS; Shen LK; Yao WH; Zhang L; He JX; Shan YJ; Ren MH
    Am J Transl Res; 2022; 14(11):7744-7757. PubMed ID: 36505302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new immune-related gene signature predicts the prognosis and immune escape of bladder cancer.
    Liu Y; Han YS; Wang JF; Pang ZQ; Wang JS; Zhang L; He JX; Shen LK; Ji B; Ding BC; Ren MH
    Cancer Biomark; 2023; 38(4):567-581. PubMed ID: 38073378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of cancer-associated fibroblast-related subtypes and the prognosis model of biochemical recurrence in prostate cancer based on single-cell and bulk RNA sequencing.
    Li T; Zhou Z; Xie Z; Fan X; Zhang Y; Zhang Y; Song X; Ruan Y
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11379-11395. PubMed ID: 37369799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-Related Genes Are Prognostic Markers for Prostate Cancer Recurrence.
    Fu M; Wang Q; Wang H; Dai Y; Wang J; Kang W; Cui Z; Jin X
    Front Genet; 2021; 12():639642. PubMed ID: 34490029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Basement membrane-related gene signature to predict biochemical recurrence in patients with prostate cancer after radical prostatectomy].
    Wang ZH; Liu Z; Zhao XD; Hu EY; Chen YH; Xu XF; Xia J; Liu YH; Dong J; Xu S; Cheng W
    Zhonghua Nan Ke Xue; 2022 Dec; 28(12):1071-1079. PubMed ID: 37846626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The signature of cuproptosis-related immune genes predicts the tumor microenvironment and prognosis of prostate adenocarcinoma.
    Yao K; Zhang R; Li L; Liu M; Feng S; Yan H; Zhang Z; Xie D
    Front Immunol; 2023; 14():1181370. PubMed ID: 37600770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of metabolism-associated molecular patterns in prostate cancer.
    Yang B; Jiang Y; Yang J; Zhou W; Yang T; Zhang R; Xu J; Guo H
    BMC Urol; 2023 Jun; 23(1):104. PubMed ID: 37280589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel senescence-associated signature to predict biochemical recurrence and immune microenvironment for prostate cancer.
    Han C; Deng Y; Yang B; Hu P; Hu B; Wang T; Liu J; Xia Q; Liu X
    Front Immunol; 2023; 14():1126902. PubMed ID: 36891298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycine Decarboxylase (GLDC) Plays a Crucial Role in Regulating Energy Metabolism, Invasion, Metastasis and Immune Escape for Prostate Cancer.
    Chen MK; Xiao ZY; Huang ZP; Xue KY; Xia H; Zhou JW; Liao DY; Liang ZJ; Xie X; Wei QZ; Zhong L; Yang JK; Liu CD; Liu Y; Zhao SC
    Int J Biol Sci; 2023; 19(15):4726-4743. PubMed ID: 37781511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of an Individualized Immune Prognostic Signature for Recurrent Prostate Cancer.
    Jin Y; Wang L; Lou H; Song C; He X; Ding M
    Comb Chem High Throughput Screen; 2021; 24(1):98-108. PubMed ID: 32593277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Liquid-Liquid Phase Separation-Related Index Associate with Biochemical Recurrence and Tumor Immune Environment of Prostate Cancer Patients.
    You Q; Chen JY; Wu XH; Xue YT; Sun JB; Wei Y; Zheng QS; Xue XY; Chen DN; Xu N
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immune escape signature predicts the prognosis and immunotherapy sensitivity for pancreatic ductal adenocarcinoma.
    Lu H; Zheng LY; Wu LY; Chen J; Xu N; Mi SC
    Front Oncol; 2022; 12():978921. PubMed ID: 36147906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel six autophagy-related genes signature for the prognostic and a miRNA-related autophagy predictor for anti-PD-1 therapy responses in prostate cancer.
    Wu L; Quan W; Yue G; Luo Q; Peng D; Pan Y; Zhang G
    BMC Cancer; 2021 Jan; 21(1):15. PubMed ID: 33402116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a Novel Nomogram to Predict Progression Based on the Circadian Clock and Insights Into the Tumor Immune Microenvironment in Prostate Cancer.
    Feng D; Xiong Q; Zhang F; Shi X; Xu H; Wei W; Ai J; Yang L
    Front Immunol; 2022; 13():777724. PubMed ID: 35154101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma cell subtypes analyzed using artificial intelligence algorithm for predicting biochemical recurrence, immune escape potential, and immunotherapy response of prostate cancer.
    Xie X; Dou CX; Luo MR; Zhang K; Liu Y; Zhou JW; Huang ZP; Xue KY; Liang HY; Ouyang AR; Ma SX; Yang JK; Zhou QZ; Guo WB; Liu CD; Zhao SC; Chen MK
    Front Immunol; 2022; 13():946209. PubMed ID: 36569837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of the Tumor Mutational Burden as a Prognostic Biomarker and Related Hub Gene Identification in Prostate Cancer.
    Wang L; Yao Y; Xu C; Wang X; Wu D; Hong Z
    Technol Cancer Res Treat; 2021; 20():15330338211052154. PubMed ID: 34806485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the αVβ3/NgR2 pathway in neuroendocrine prostate cancer.
    Testa A; Quaglia F; Naranjo NM; Verrillo CE; Shields CD; Lin S; Pickles MW; Hamza DF; Von Schalscha T; Cheresh DA; Leiby B; Liu Q; Ding J; Kelly WK; Hooper DC; Corey E; Plow EF; Altieri DC; Languino LR
    Matrix Biol; 2023 Dec; 124():49-62. PubMed ID: 37956856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock protein family A member 8 is a prognostic marker for bladder cancer: Evidences based on experiments and machine learning.
    Liu Y; Pang ZQ; Wang JS; Wang JF; He JX; Ji B; Zhang L; Ren MH
    J Cell Mol Med; 2023 Dec; 27(24):3995-4008. PubMed ID: 37771276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel ferroptosis-related gene prognostic index for prognosis and response to immunotherapy in patients with prostate cancer.
    Wang Y; Fan J; Chen T; Xu L; Liu P; Xiao L; Wu T; Zhou Q; Zheng Q; Liu C; Chan FL; Wu D
    Front Endocrinol (Lausanne); 2022; 13():975623. PubMed ID: 36034466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.